2666-3287

JAAD International

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 999 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact999 DOIs
2

Attach ORCID iDs across 420 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact420 DOIs
3

Deposit reference lists for 50 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact50 DOIs

DOIs for this ISSN

Showing the top 5 of 999 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The global burden of skin cancer: A longitudinal analysis fr… (10.1016/j.jdin.2020.10.013)
Abstract ORCID
124.71 311
2 Skin manifestations of COVID-19: A worldwide review (10.1016/j.jdin.2020.12.003)
Abstract ORCID
99.78 98
3 The global, regional, and national burden of fungal skin dis… (10.1016/j.jdin.2020.10.003)
Abstract ORCID
98.19 91
4 The global, regional, and national burden of atopic dermatit… (10.1016/j.jdin.2020.10.002)
Abstract ORCID
93.46 73
5 Hidradenitis suppurativa is an autoinflammatory keratinizati… (10.1016/j.jdin.2020.05.005)
Abstract ORCID
93.17 72
6 Burden of skin disease and associated socioeconomic status i… (10.1016/j.jdin.2020.10.006)
Abstract ORCID
92.87 71
7 Teledermatology in the COVID-19 pandemic: A systematic revie… (10.1016/j.jdin.2021.07.007)
Abstract ORCID
90.65 64
8 Trichodynia and telogen effluvium in COVID-19 patients: Resu… (10.1016/j.jdin.2021.07.006)
Abstract ORCID
87.79 56
9 Hidradenitis suppurativa in patients of color is associated… (10.1016/j.jdin.2021.01.007)
Abstract ORCID
86.21 52
10 Epidemiology of Stevens-Johnson syndrome and toxic epidermal… (10.1016/j.jdin.2023.06.014)
Abstract ORCID
85.80 51
11 Trends of cutaneous basal cell carcinoma, squamous cell carc… (10.1016/j.jdin.2021.05.006)
Abstract ORCID
84.95 49
12 Clinical manifestations and treatment outcomes in prurigo pi… (10.1016/j.jdin.2021.03.003)
Abstract ORCID
81.16 41
13 Acute generalized exanthematous pustulosis: Epidemiology, cl… (10.1016/j.jdin.2020.12.004)
Abstract ORCID
78.99 37
14 Impact of facial and truncal acne on quality of life: A mult… (10.1016/j.jdin.2021.03.002)
Abstract ORCID
78.99 37
15 Burden of skin disease and associated socioeconomic status i… (10.1016/j.jdin.2020.07.001)
Abstract ORCID
78.41 36
16 Best practices for implementing ChatGPT, large language mode… (10.1016/j.jdin.2023.10.001)
Abstract ORCID
78.41 36
17 Personal protective equipment-related occupational dermatose… (10.1016/j.jdin.2021.08.004)
Abstract ORCID
77.82 35
18 Hydrocolloid dressing versus conventional wound care after d… (10.1016/j.jdin.2021.11.002)
Abstract ORCID
77.20 34
19 The tumor genetics of acral melanoma: What should a dermatol… (10.1016/j.jdin.2020.07.004)
Abstract ORCID
76.57 33
20 Prevalence of prurigo nodularis in the United States of Amer… (10.1016/j.jdin.2020.10.009)
Abstract ORCID
75.93 32
21 Late-onset development of psoriasis in Japan: a population-b… (10.1016/j.jdin.2020.10.011)
Abstract ORCID
75.26 31
22 Complementary and alternative medicine treatments for common… (10.1016/j.jdin.2020.11.001)
Abstract ORCID
74.57 30
23 Hidradenitis suppurativa prevalence in Berekum, Ghana: A cro… (10.1016/j.jdin.2020.02.001)
Abstract ORCID
73.86 29
24 Association between chronic pruritus, depression, and insomn… (10.1016/j.jdin.2021.02.004)
Abstract ORCID
73.86 29
25 Generalized pustular psoriasis in Brazil: A public claims da… (10.1016/j.jdin.2021.12.001)
Abstract ORCID
73.12 28
26 Skin cancers arising within tattoos: A systematic review (10.1016/j.jdin.2024.03.015)
Abstract ORCID
73.12 28
27 Accuracy and efficiency of telemedicine in atopic dermatitis (10.1016/j.jdin.2020.08.002)
Abstract ORCID
72.36 27
28 Clinical and epidemiologic features of psoriasis patients in… (10.1016/j.jdin.2020.06.002)
Abstract ORCID
71.57 26
29 Two-year efficacy, safety, and drug survival of dupilumab fo… (10.1016/j.jdin.2021.06.001)
Abstract ORCID
71.57 26
30 Cutaneous reactions to COVID-19 vaccines: A review (10.1016/j.jdin.2022.01.011)
Abstract ORCID
71.57 26
31 Association between alopecia areata and COVID-19: A systemat… (10.1016/j.jdin.2022.02.002)
Abstract ORCID
70.75 25
32 Therapeutic education in atopic dermatitis: A position paper… (10.1016/j.jdin.2021.01.001)
Abstract ORCID
69.90 24
33 Risk factors and drugs that trigger the onset of Stevens–Joh… (10.1016/j.jdin.2022.12.002)
Abstract ORCID
69.90 24
34 Predictive factors of quality of life in chronic pruritus pa… (10.1016/j.jdin.2022.12.005)
Abstract ORCID
69.01 23
35 Association between atopic dermatitis and COVID-19 infection… (10.1016/j.jdin.2021.12.007)
Abstract ORCID
68.09 22
36 Phenotypic differences of atopic dermatitis stratified by ag… (10.1016/j.jdin.2022.08.026)
Abstract ORCID
68.09 22
37 Multicenter prospective blinded melanoma detection study wit… (10.1016/j.jdin.2023.10.011)
Abstract ORCID
68.09 22
38 Dupilumab improves pruritus and skin lesions in patients wit… (10.1016/j.jdin.2024.03.025)
Abstract ORCID
68.09 22
39 Prevalence and patient-reported outcomes of noncommunicable… (10.1016/j.jdin.2020.03.003)
Abstract ORCID
67.12 21
40 Prevalence of baseline comorbidities in patients with atopic… (10.1016/j.jdin.2020.05.002)
Abstract ORCID
67.12 21
41 Modulation of the kappa and mu opioid axis for the treatment… (10.1016/j.jdin.2022.03.007)
Abstract ORCID
67.12 21
42 A randomized controlled trial comparing video-assisted infor… (10.1016/j.jdin.2020.03.005)
Abstract ORCID
66.11 20
43 Gaps and recommendations for clinical management of truncal… (10.1016/j.jdin.2021.06.007)
Abstract ORCID
66.11 20
44 Use of primary care services among patients with chronic ski… (10.1016/j.jdin.2020.10.010)
Abstract ORCID
65.05 19
45 Effectiveness and clinical predictors of drug survival in ps… (10.1016/j.jdin.2020.10.012)
Abstract ORCID
65.05 19
46 Identifying gaps and providing recommendations to address sh… (10.1016/j.jdin.2021.06.006)
Abstract ORCID
65.05 19
47 Side effects of steroid-sparing agents in patients with bull… (10.1016/j.jdin.2022.07.005)
Abstract ORCID
65.05 19
48 Social media dermatologic advice: Dermatology without dermat… (10.1016/j.jdin.2023.05.004)
Abstract ORCID
65.05 19
49 Efficacy of intralesional sodium thiosulfate for the treatme… (10.1016/j.jdin.2020.07.002)
Abstract ORCID
63.94 18
50 A comparison study of outcome measures for epidermolysis bul… (10.1016/j.jdin.2020.12.007)
Abstract ORCID
63.94 18